E815
TEAS SECTION 8 & 15 RECEIVED
05/06/2026
Voltar para busca
Dado oficial do USPTO
QDB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
06/06/2026
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
26/01/2018
Data de registro
13/04/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/04/2021
Última transação
06/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
04/09/2018
Primeiro uso no comércio
04/09/2018
Código do desenho
3
Tipo de titular
03
Localização do titular
Chapel Hill, NC, US
Examinador
VOHRA, SANJEEV KUMAR
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the term "QDB", where the letter "Q" is designed as a magnifying glass encompassing the letters "DB".
Titulares e representantes
Titulares
Quanticision Diagnostics, Inc
Representantes
Quanticision Diagnostics, Inc
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; diagnostic preparations for scientific use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Classe 5
Diagnostic agentspreparations and substances for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents and media for medical and veterinary diagnostic purposes
Classe 42
Computer diagnostic services; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; providing a website featuring information about investigational medical devicesdiagnostics and drugs; providing medical testing services and information in the field of cancer research and disease classification
Classe 44
Consulting services in the fields of diagnostic medical testing and nutrition; health care servicesproviding a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes; providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/04/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
13/04/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/03/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/03/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/03/2021
IUAF
USE AMENDMENT FILED
22/02/2021
EISU
TEAS STATEMENT OF USE RECEIVED
22/02/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/09/2020
EX4G
SOU EXTENSION 4 GRANTED
18/09/2020
EXT4
SOU EXTENSION 4 FILED
20/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
20/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/03/2020
EX3G
SOU EXTENSION 3 GRANTED
05/03/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/03/2020
EXT3
SOU EXTENSION 3 FILED
24/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
24/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/08/2019
EX2G
SOU EXTENSION 2 GRANTED
24/08/2019
EXT2
SOU EXTENSION 2 FILED
24/08/2019
EEXT
SOU TEAS EXTENSION RECEIVED
24/08/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/02/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/02/2019
EX1G
SOU EXTENSION 1 GRANTED
26/02/2019
EXT1
SOU EXTENSION 1 FILED
26/02/2019
EEXT
SOU TEAS EXTENSION RECEIVED
26/02/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/08/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2018
PUBO
PUBLISHED FOR OPPOSITION
03/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/05/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
16/05/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/05/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
16/05/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/05/2018
DOCK
ASSIGNED TO EXAMINER
09/05/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2018
NWAP
NEW APPLICATION ENTERED
30/01/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QDB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.